NCT01465295

Brief Summary

The purpose of this clinical trial is to study a new method of treatment for patients who are diagnosed with idiopathic scoliosis and have abnormal and increasing curvature of the spine. The treatment consists of the surgical implantation of a new medical device called the "HemiBridge™ Clip". This medical implant device has never been used in humans. SpineForm, LLC, the developer of the HemiBridgeTM System has designed this scientific clinical trial, to evaluate the safety of the use of this device in humans. Information collected from patients treated with this new device shall be used to determine the initial safety of the new device. The FDA has approved the use of the HemibridgeTM System for this research study in 6 (six) pediatric patients who have idiopathic scoliosis. This procedure is intended to stop additional curvature of the spine by redirecting growth of the bones of the spine (vertebrae). To accomplish this, the patient undergoes a surgical procedure to securely attach small metal clips (HemiBridge™ Clips) to the outer side of each vertebra involved in the curvature. The HemiBridge™ Clip forms a "bridge" between each vertebra and is intended to hold the vertebrae in place to prevent the spine from curving any further.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 28, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 4, 2011

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2017

Completed
Last Updated

February 5, 2018

Status Verified

February 1, 2018

Enrollment Period

6.4 years

First QC Date

October 28, 2011

Last Update Submit

February 2, 2018

Conditions

Keywords

ScoliosisAdolescent Idiopathic Scoliosis (AIS)Scoliosis treatmentFusionless spinal surgeryVertebral staplingSpinal staplingNon-fusionSpinal curvatureCurvature of the spineSpinal bracing alternativeHemiBridgeSpineFormDr. Eric WallDr. George ThompsonSpinal clipCincinnati Children's Hospital Medical CenterUniversity Hospitals Case Medical Center, Rainbow Babies

Outcome Measures

Primary Outcomes (1)

  • Acute Safety: Incidence, relatedness (relationship to procedure and device), seriousness and severity of Adverse Events By Participant

    Incidence, relatedness (relationship to procedure and device), seriousness and severity of Adverse Events By Participant

    1 month post-operative

Study Arms (1)

HemiBridge

EXPERIMENTAL

Patients meeting eligibility criteria will be treated with the HemiBridge System.

Device: Mechanical hemiepiphysiodesis using the HemiBridge System

Interventions

Surgical application of mechanical hemiepiphysiodesis using the HemiBridge device.

HemiBridge

Eligibility Criteria

Age10 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • \- Patients must meet all the criteria to be enrolled in this study:
  • Trial subject population will involve patients who are skeletally immature, who have a diagnosis of idiopathic scoliosis with a single main thoracic curve Cobb angle 25° to 40° and Lenke Type 1A or 1B.
  • Chronologic age:
  • Males ≥ 10 years
  • Females ≥ 10 years
  • Females pre-menarchal at screening examination
  • Bone age as confirmed by radiographs of left hand and wrist according to the "Atlas Matching" method of Greulich and Pyle:
  • Females: ≥ 8 years and 10 months not to exceed 13 years
  • Males: ≥ 10 years not to exceed 15 years
  • Skeletal immaturity (Risser grade 0 and the triradiate cartilage is open) as determined by standing, upright PA radiograph. If radiographic Risser grade results are indeterminate, the bone age from the Atlas Matching will prevail.
  • Main thoracic Cobb angle of 25° to 40° as determined from standing, upright PA radiographs where the end vertebra are between or including T3 and L1 without wearing a brace
  • Clinical diagnosis of idiopathic scoliosis with a single main thoracic curve as determined with measurement on standing posterior- anterior PA radiographs.
  • Defined as a single thoracic curve where either: central sacral vertical line (CSVL) passes between the pedicles of the apical lumbar vertebra; or the CSVL touches the lumbar apical body(ies) (Lenke Type 1A or 1B, respectively)
  • Achievable anatomical fit as determined by calibrated standing PA film:
  • Disc height not exceeding 10 mm at each spinal level to be instrumented relative to location of the probable implant and
  • +5 more criteria

You may not qualify if:

  • Non-idiopathic scoliosis
  • Males and females chronological age \< 10 years
  • Triradiate cartilage is closed as determined on the standing PA radiograph at baseline screening
  • Any curve type that does not meet definition of Lenke 1A or 1B
  • Any main thoracic deformity that measures \< 25° or \> 40° Cobb angle
  • Any main thoracic deformity that includes vertebral levels including and cranial to T2
  • Any main thoracic deformity that includes vertebral levels including and caudal to L2
  • Prior thoracotomy, thoracostomy or any spine surgery
  • T3-T12 kyphosis \> 40° (T4 or T5-T12 if visualization impaired at T3)
  • Known history or existing malignancy, or any systemic or local infection
  • Spinal cord abnormalities that require treatment
  • Presence of neurological deficit (motor grades 0-4, sensory grades 0-1, reflexes grade 0 or 5 or asymmetry of deep tendon reflexes \> 2 from right to left)
  • Insulin-dependent diabetes
  • Severe asthma
  • Reduced pulmonary function, defined as \< 60% of predicted value (Forced expiratory volume in one second \[FEV1\] divided by forced vital capacity \[FVC\]) or Subject has moderately severe or worse ventilatory limitation defined as \< 60% of predicted value of the forced vital capacity \[FVC\] for age, race, sex and height (with height determined by arm span in patients with scoliosis and reference equations derived from the data of Wang et al 199329.)
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States

Location

University Hospitals Case Medical Center - Rainbow Babies & Children's Hospital

Cleveland, Ohio, 44115, United States

Location

Related Publications (12)

  • Bunge EM, de Koning HJ; brace trial group. Bracing patients with idiopathic scoliosis: design of the Dutch randomized controlled treatment trial. BMC Musculoskelet Disord. 2008 Apr 22;9:57. doi: 10.1186/1471-2474-9-57.

    PMID: 18430217BACKGROUND
  • Guille JT, D'Andrea LP, Betz RR. Fusionless treatment of scoliosis. Orthop Clin North Am. 2007 Oct;38(4):541-5, vii. doi: 10.1016/j.ocl.2007.07.003.

    PMID: 17945133BACKGROUND
  • Wiggins GC, Shaffrey CI, Abel MF, Menezes AH. Pediatric spinal deformities. Neurosurg Focus. 2003 Jan 15;14(1):e3. doi: 10.3171/foc.2003.14.1.4.

    PMID: 15766220BACKGROUND
  • Lonner BS. Emerging minimally invasive technologies for the management of scoliosis. Orthop Clin North Am. 2007 Jul;38(3):431-40; abstract vii-viii. doi: 10.1016/j.ocl.2007.03.011.

    PMID: 17629990BACKGROUND
  • Arlet V. Anterior thoracoscopic spine release in deformity surgery: a meta-analysis and review. Eur Spine J. 2000 Feb;9 Suppl 1(Suppl 1):S17-23. doi: 10.1007/s005860000186.

    PMID: 10766053BACKGROUND
  • Vaccaro AR, Regan JJ, Crawford AH, Benzel EC, Anderson DG. Complications of pediatric and adult spinal surgery. Chapter 7, Postarthrodesis Adjacent Segment Degeneration, Marcel Dekker, New York, 2004; p 82.

    BACKGROUND
  • Andersen MO, Christensen SB, Thomsen K. Outcome at 10 years after treatment for adolescent idiopathic scoliosis. Spine (Phila Pa 1976). 2006 Feb 1;31(3):350-4. doi: 10.1097/01.brs.0000197649.29712.de.

    PMID: 16449910BACKGROUND
  • Dolan LA, Weinstein SL. Surgical rates after observation and bracing for adolescent idiopathic scoliosis: an evidence-based review. Spine (Phila Pa 1976). 2007 Sep 1;32(19 Suppl):S91-S100. doi: 10.1097/BRS.0b013e318134ead9.

    PMID: 17728687BACKGROUND
  • Bylski-Austrow DI, Wall EJ, Rupert MP, Roy DR, Crawford AH. Growth plate forces in the adolescent human knee: a radiographic and mechanical study of epiphyseal staples. J Pediatr Orthop. 2001 Nov-Dec;21(6):817-23.

    PMID: 11675562BACKGROUND
  • Wall EJ, Bylski-Austrow DI, Kolata RJ, Crawford AH. Endoscopic mechanical spinal hemiepiphysiodesis modifies spine growth. Spine (Phila Pa 1976). 2005 May 15;30(10):1148-53. doi: 10.1097/01.brs.0000162278.68000.91.

    PMID: 15897828BACKGROUND
  • Bylski-Austrow DI, Wall EJ, Glos DL, Ballard ET, Montgomery A, Crawford AH. Spinal hemiepiphysiodesis decreases the size of vertebral growth plate hypertrophic zone and cells. J Bone Joint Surg Am. 2009 Mar 1;91(3):584-93. doi: 10.2106/JBJS.G.01256.

    PMID: 19255218BACKGROUND
  • Wall EJ, Reynolds JE, Jain VV, Bylski-Austrow DI, Thompson GH, Samuels PJ, Barnett SJ, Crawford AH. Spine Growth Modulation in Early Adolescent Idiopathic Scoliosis: Two-Year Results of Prospective US FDA IDE Pilot Clinical Safety Study of Titanium Clip-Screw Implant. Spine Deform. 2017 Sep;5(5):314-324. doi: 10.1016/j.jspd.2017.02.004.

Related Links

MeSH Terms

Conditions

ScoliosisSpinal Curvatures

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • Joseph E Reynolds, MBA

    SpineForm LLC

    STUDY DIRECTOR
  • Eric J Wall, MD

    Children's Hospital Medical Center, Cincinnati

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2011

First Posted

November 4, 2011

Study Start

August 1, 2011

Primary Completion

December 29, 2017

Study Completion

December 29, 2017

Last Updated

February 5, 2018

Record last verified: 2018-02

Locations